ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

Zerhouni to Cancer Researchers: “Stay Calm, Cool” About Funding- And Beware of Myths.

June 16, 2006

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

McKesson To Purchase US Oncology

November 5, 2010

GM To Offer Three Awards of $1000,000 Each To Cancer Investigators

September 8, 1978